Kristinn D. Gretarsson appointed CEO of ORF Genetics and Sif Cosmetics
ORF Genetics announced today that Mr. Kristinn D. Gretarsson has been
appointed CEO of the company and its subsidiary, Sif Cosmetics.
Endotoxin-free growth factors for stem cell research in Trends in Biotechnology
The advantages of endotoxin-free production of growth factors and other
recombinant proteins in barley is the subject of a review article by Dr.
Audur Magnusdottir and colleges at ORF Genetics, published in Trends in
ORF Genetics‘ ISOkine growth factors– The Best European Biotechnology Product in 2013
At the European Biotechnology Congress in Bratislava last week, the
ISOkine growth factors produced by ORF Genetics were chosen this year’s
Best Biotechnology Product in the category of innovative products that
solve or tackle important problems in human health. The awards are given
in recognition of distinguished contribution to the European
Biotechnology Industry, by a small or medium sized European company.
ORF Genetics to offer endotoxin- and animal-free FGFb and mLIF for stem cell research
ORF Genetics announced today that the company has added endotoxin- and
animal-free human Fibroblast Growth Factor Basic (FGF basic) and mouse
Leukemia Inhibitory Factor (mouse LIF) to its portfolio of growth
factors for stem cell research.